Status:
UNKNOWN
Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19
Lead Sponsor:
Coordinación de Investigación en Salud, Mexico
Collaborating Sponsors:
Instituto Mexicano del Seguro Social
Conditions:
SARS-CoV-2
Eligibility:
All Genders
16+ years
Brief Summary
The SARS-CoV-2 infection in the airway epithelium induces cytopathic effects and the cessation of ciliary movement. Increased cytokines and chemokines have been reported to be associated with the seve...
Eligibility Criteria
Inclusion
- Patients over 16 years old with positive molecular diagnosis of Covid-19, in the Laboratory of IMSS
Exclusion
- Patients with immunosuppressive diseases: HIV +, Hepatitis C virus, primary immunodeficiencies, rheumatoid arthritis, lupus erythematosus and patients under treatment with immunosuppressants
Key Trial Info
Start Date :
April 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 15 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04423640
Start Date
April 15 2020
End Date
August 15 2020
Last Update
August 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMAE Hospital de Especialidades del Centro Médico Nacional Siglo XXI, IMSS.
Mexico City, Mexico City, Mexico, 06720